Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor in Irritable Bowel Syndrome With Constipation
NCT05995899Phase 4Completed
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenapanor in irritable bowel syndrome (IBS). Started Feb 2024; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05995899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05995899.